Exam was notable for an irritable female oriented to self.
Labs were notable for initial glucose > than assay, K 7.6; chem 7 revealed glucose 1369, Na 121, K 6.0, bicarb 8, creat 2.2, gap 34.
EKG was notable for ST segment elevation in V1-V2.
A Code STEMI was called and the patient was given asa, plavix 300mg, heparin bolus, integrillin bolus as well as started on an insulin drip with bolus of 10u and rate of 8u.
EKG was repeated after insulin drip was started with improvement in the ST segments.
Repeat labs were notable for glucose 1135, K 4.1, bicarb 5, creatinine 2.2 and an anion gap of 34. .
Neck: Supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen:  Soft, non-tender, non-distended, bowel sounds present, mild tenderness to palpation over epigastrum, no organomegaly GU: foley in place Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CN II-XII Intact, Decreased sensation to light touch bilateral fingers of bilateral upper extremity and feet, Bilateral foot drop.
Pertinent Results: Labs on Admission: [**2135-7-3**] 11:15AM BLOOD WBC-17.4*# RBC-3.41* Hgb-10.0* Hct-35.7*# MCV-105*# MCH-29.3 MCHC-28.0*# RDW-14.1 Plt Ct-466* [**2135-7-3**] 11:15AM BLOOD Neuts-84.0* Lymphs-12.2* Monos-3.2 Eos-0.2 Baso-0.3 [**2135-7-3**] 11:15AM BLOOD PT-13.6* PTT-29.5 INR(PT)-1.2* [**2135-7-3**] 11:15AM BLOOD Glucose-1369* UreaN-39* Creat-2.2*# Na-121* K-6.0* Cl-80* HCO3-7* AnGap-40* [**2135-7-3**] 11:15AM BLOOD ALT-17 AST-22 AlkPhos-125* TotBili-0.4 [**2135-7-3**] 11:15AM BLOOD Lipase-61* [**2135-7-3**] 11:15AM BLOOD cTropnT-<0.01 [**2135-7-3**] 03:15PM BLOOD CK-MB-5 [**2135-7-4**] 09:50AM BLOOD CK-MB-6 cTropnT-<0.01 [**2135-7-3**] 11:15AM BLOOD Calcium-8.2* Phos-7.4*# Mg-2.3 [**2135-7-3**] 05:58PM BLOOD Osmolal-327* [**2135-7-3**] 05:58PM BLOOD TSH-2.1 [**2135-7-6**] 07:20AM BLOOD HIV Ab-NEGATIVE [**2135-7-3**] 05:58PM BLOOD ASA-4.2 Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG .
Labs on Discharge: [**2135-7-11**] 07:10AM BLOOD WBC-4.9 RBC-2.74* Hgb-8.2* Hct-25.8* MCV-94 MCH-30.1 MCHC-32.0 RDW-15.9* Plt Ct-359 [**2135-7-11**] 07:10AM BLOOD Glucose-490* UreaN-13 Creat-1.1 Na-128* K-5.1 Cl-95* HCO3-29 AnGap-9 [**2135-7-11**] 07:10AM BLOOD Calcium-8.4 Phos-3.5 Mg-1.7 .
Microbiology: Urine Cx ([**7-3**]): Final No Growth Blood Cx ([**7-3**] - 14 - 15): Final No Growth Catheter Tip: [**2135-7-4**] 11:17 am CATHETER TIP-IV      Source: lft fem.
**FINAL REPORT [**2135-7-6**]**     WOUND CULTURE (Final [**2135-7-6**]):       STAPHYLOCOCCUS, COAGULASE NEGATIVE.
Urine Culture ([**7-4**]): [**2135-7-4**] 4:58 pm URINE      Source: Catheter.
**FINAL REPORT [**2135-7-7**]**     URINE CULTURE (Final [**2135-7-7**]):       ESCHERICHIA COLI.
RESPIRATORY CULTURE (Final [**2135-7-8**]):       HEAVY GROWTH Commensal Respiratory Flora.
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              STAPH AUREUS COAG +                              | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN----------   =>8 R OXACILLIN-------------<=0.25 S TRIMETHOPRIM/SULFA---- <=0.5 S .
VIRAL CULTURE (Preliminary):    No Virus isolated so far.
Urine Culture: [**2135-7-6**] 1:29 pm URINE      Source: CVS.
**FINAL REPORT [**2135-7-9**]**     URINE CULTURE (Final [**2135-7-9**]):       ESCHERICHIA COLI.
Imaging: CXR ([**7-3**]): 1.
CT Head ([**7-3**]): No evidence of acute intracranial abnormality.
In case of clinical concern for acute infarction, an MRI can be obtained.
CXR ([**7-5**]): No evidence of pneumonia.
Venous Duplex ([**7-8**]): No evidence of thrombosis of the left internal jugular or subclavian vein.
Brief Hospital Course: 56 YO F with DM1 c/b multiple episodes of DKA, polyneuropathy and gastroparesis, HCV genotype 1A, [**Doctor Last Name 933**] disease, and hypertension presenting with altered mental status found to have DKA.
Mental Status Change/DKA: On presentation to ED, exam was notable for an irritable female oriented to self.
Labs were notable for initial glucose > than assay, K 7.6; chem 7 revealed glucose 1369, Na 121, K 6.0, bicarb 8, creat 2.2, anion gap 34.
CXR clear on admission.
Blood cultures drawn and negative to date.
CT head performed without acute intracranial pathology.
Initially patient given 1/2 NS with potassium and regular insulin gtt with q1H glucose checks and Q4H electrolytes.
Blood sugar improved and anion gap closed - mental status improved.
Regimen at discharge was Lantus 25U in the morning, 25U in the evening and humalog insulin sliding scale.
Throat culture revealed beta strep non group A rate growth.
Viral culture was negative.
ENT consulted for potential biopsy of ulcerative lesion.
On admission EKG was notable for ST segment elevation in V1-V2.
EKG was repeated after insulin drip was started with improvement in the ST segments.
Cardiac enzymes negative.
Release 12 hr q8H -Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr -Oxycodone-Acetaminophen 5-325 mg Tablet q6H PRN -Diazepam 2 mg Tablet Sig: One (1) Tablet PO q12H PRN -Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID -Losartan 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
-Insulin Glargine 25u qam, 20u q4:30 pm -Zomig 2.5mg nausea prn -Miralax 17gm PRN - hydroxyzine 25mg PO Prn - on d/c summary but not on current med list     ---> Humalog 100 unit/mL Solution QID  Discharge Medications: 1.
Release 12 hr Sig: One (1) Capsule, Sust.
Release 12 hr PO Q 8H (Every 8 Hours).
Please check your blood sugars prior to eating and at bedtime.
The following changes were made to your medication regimen: - START: Acyclovir for 4 more days - START: Macrobid (Nitrofurantoin) for 4 more days - CHANGE: Lantus Insulin to 25Units in morning and 25 Units in the evening.
